Fundamental Data for JNJ

JOHNSON &(NYSE:JNJ)

Johnson & Johnson is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. The company''s worldwide business is divided into three segments: Consumer; Pharmaceutical; and Professional.

# Employees: 118700

Address: One Johnson & Johnson Plaza,New Brunswick,NJ,USA

Phone: 732-524-0400

Fax: 732-214-0332

Website: www.jnj.com

Email:

Sector: Medical

Industry: MED-DRUGS

Executive Officers

William C. Weldon (Chmn.; C.E.O.; Dir.)

Christine A. Poon (Vice-Chmn.)

Colleen A. Goggins (Worldwide Chmn.; Consumer Group)

Sherilyn S. Mccoy (Worldwide Chmn.; Surgical Care Group)

Donald M. Casey Jr. (Worldwide Chmn.; Comprehensive Care Group,)

Dividend

Ex-Dividend Date: 11/20/2009

Annual Dividend: $1.96

Current Dividend Yield: $3.15

Dividend Paid (3 months): $0.49

Indicated Dividend: $0.43

Earnings

Last Earnings Date: 9/30/2009

Next Earnings Date(Expected): 1/19/2010

Mean EPS (Next Qtr): $0.97

Mean EPS (Year): $4.58

Mean Estimate(Long Term): $7.95

P/E Ratio(Based on EPS estimate): 13.610

Number of Estimates: 22

Shares Performance

Period	JNJ	Compare to S&P
YTD	4.15 %	-13.81 %
4 Weeks	2.92 %	1.81 %
12 Weeks	3.35 %	-2.56 %

Shares Information

Analyst Coverage: Y

Avg Volume: 12827199

Shares Outstanding: 2755M

Market Cap: $171.71B

52 Week High: $62.53

52 Week Low: $46.60

P/E Ratio: 13.690

PEG Ratio: 1.710

Split: On 6/13/2001 JNJ split by factor of 2.000

Earnings Performance

EPS Growth in Last Quarter: 4.35 %

EPS Growth in Last Year: 2.56 %

Sales Growth in Last Quarter: -1.04 %

Sales Growth in Last Quarter: -5.28 %

Financials

Qtr Book Value: $3.41

Cash Flow/Share: $10.99

Change in Payout Ratio: 0.030

Price/Sales: 2.840